2575. Using the IDSA diarrhea guidelines in an era of changing diagnostics
Session: Mini-Symposium: Does Detection Equal Infection: Application of the IDSA Diarrhea Infectious Disease Guidelines in an Era of Changing Diagnostics
Sunday, October 7, 2018: 8:00 AM
Room: W 2001-2003
Andi L. Shane, MD, MPH, MSc, FIDSA, FPIDS, Pediatrics, Emory University School of Medicine, Atlanta, GA

Andi L. Shane, MD, MPH, MSc, is an Associate Professor of Pediatrics (Infectious Diseases) and the Interim Division Director at the Emory Children's Pediatric Institute Atlanta, Georgia. She is also a Marcus Professor of Hospital Epidemiology and Infection Control for the Children's Healthcare of Atlanta system. Dr. Shane received her Bachelor of Arts degree from the University of Pennsylvania followed by a Master of Public Health degree from the Mailman School of Public Health at Columbia University. She received her medical degree from Louisiana State University School of Medicine in New Orleans and a Master of Science degree from Emory University. She completed an internship, residency, and chief residency in pediatrics at Albert Einstein College of Medicine in the Bronx, New York. She was an Epidemic Intelligence Service Officer at the Centers for Disease Control and Prevention (CDC) in the former Foodborne and Diarrheal Diseases Branch. She completed a fellowship in pediatric infectious disease at the University of California, San Francisco. Dr. Shane served as the co-chair of the Infectious Disease Society of America (IDSA) Panel to review the guidelines for infectious diarrhea management. She is an elected member of the Pediatric Infectious Disease Society (PIDS) Board of Directors and serves as the PIDS representative to the World Society of pediatric Infectious Diseases (WSPID) Board of Directors and the WSPID Education Committee. She serves as the medical director of hospital epidemiology and infection control for the Children's Healthcare of Atlanta system. An active clinical researcher, Dr. Shane has been the site principal and co-principal investigator for several studies conducted at Emory University’s National Institute of Health (NIH) Vaccine and Treatment Evaluation Network (VTEU) as well as through the Collaborative Antiviral Study Group (CASG). She is involved in educational efforts to incorporate clinical research activities into the curricula of medical students, residents and clinical fellows both in the United States and in Ethiopia. She has contributed to guidelines and policies relevant to the management and prevention of childcare associated infections and the applications of probiotics for the management of enteric infections.


Disclosures:

A. L. Shane, International Scientific Association of Probiotics and Prebiotics: Member , Reimbursement of travel and lodging for attendance and presentations at international scientific meetings 2016 and prior and support for attendance at meeting at FDA in 2017 to discuss probiotic and prebiotic research .

Previous Abstract | Next Abstract >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.